PP1 treatment for strokes

PP1 suppression of Src tyrosine kinases can prevent the neuronal damage in strokes by influencing brain vessel permeability.The only established treatment for acute ischaemic stroke is thrombolysis, but this is associated with the risk of severe, sometimes life threatening haemorrhage. In the February issue of Nature Medicine researchers from The Scripps Research Institute in California suggest a potential new treatment for stroke.Tissue ischaemia results in an overproduction of vascular endothe

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

PP1 suppression of Src tyrosine kinases can prevent the neuronal damage in strokes by influencing brain vessel permeability.

The only established treatment for acute ischaemic stroke is thrombolysis, but this is associated with the risk of severe, sometimes life threatening haemorrhage. In the February issue of Nature Medicine researchers from The Scripps Research Institute in California suggest a potential new treatment for stroke.

Tissue ischaemia results in an overproduction of vascular endothelial growth factor (VEGF), which in turn increases the permeability of blood vessels in the brain. These leaky vessels lead to swelling in the brain and subsequent neuronal damage. A family of tyrosine kinase molecules called the Src kinases links VEGF and increased vascular permeability.

Robert Paul and colleagues show that suppression of Src activity decreases vascular permeability, with mice deficient in Src having decreased infarct volumes and reduced oedema (Nat Med 2001, 7:222-227). Using the drug PP1, which ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Tudor Toma

    This person does not yet have a bio.
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Discover a serum-free way to produce dendritic cells and macrophages for cell therapy applications.

Optimizing In Vitro Production of Monocyte-Derived Dendritic Cells and Macrophages

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with Lipid Nanoparticles

Thermo Fisher Logo